News

The Johnson & Johnson Innovation Centre in London facilitated the research agreement. Under terms of the agreement, Nextera will, with use of its unique technology platform, undertake certain

The companies will start a managed access program in selected countries for NP001, Neuraltus’ investigational therapy for ALS. Coverage is planned to be expanded in the next year.

Intuniv, a drug for the treatment of ADHD in children and adolescents from 6 to 17 years old, is already licensed in the US and Canada. Shire said

Last year, Sun Pharma acquired Ranbaxy Laboratories in an all-stock transaction totalling equity value of $3.2bn. However, earlier this year Sun Pharma said as a part of the

The FDA will review Kyprolis in combination with dexamethasone for patients with relapsed multiple myeloma following prior treatment with at least one therapy, based on findings from the

Perrigo said that its Board of Directors has reviewed Mylan’s unsolicited tender offer to acquire all of the outstanding shares of Perrigo and, in consultation with its financial

Thirteen more national marketing authorizations in Europe are expected in the coming months. Simultaneously to this ongoing European decentralized procedure, registrations are to take place in 33 countries

National Association of Chain Drug Stores (NACDS) President and CEO Steven C. Anderson, IOM, CAE, issued a statement about the U.S. House of Representatives Ways and Means Committee’s

The option exercise, part of the $45 million Ebola program grant announced in April when Inovio received an initial $21 million award, was contingent upon Inovio successfully leading